{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:43:30Z","timestamp":1791420210677,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Vetmedica, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002477","name":"East Carolina University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.018","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T17:01:28Z","timestamp":1400086888000},"page":"3977-3981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Raccoonpoxvirus safety in immunocompromised and pregnant mouse models"],"prefix":"10.1016","volume":"32","author":[{"given":"Gwendolyn J.B.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Boles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.05.018_bib0005","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.it.2004.10.002","article-title":"25 years since the eradication of smallpox: why poxvirus research is still relevant","volume":"25","author":"Mahalingam","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo basin","volume":"340","author":"Chen","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0015","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMc062788","article-title":"Monkeypox without exanthem","volume":"356","author":"Lewis","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0020","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4269\/ajtmh.2007.77.1150","article-title":"Prevalence of antibodies against orthopoxviruses among residents of Likouala region, Republic of Congo: evidence for monkeypox virus exposure","volume":"77","author":"Lederman","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-2003-38051","article-title":"Human cowpox\/catpox infection. A potentially unrecognized disease","volume":"128","author":"Steinborn","year":"2003","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.0736-8046.2004.21602.x","article-title":"Patient demographics and utilization of health care services for molluscum contagiosum","volume":"21","author":"Molino","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","article-title":"Zoonotic poxvirus infections in humans","volume":"17","author":"Lewis-Jones","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/viro.2000.0603","article-title":"An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine","volume":"277","author":"Damaso","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMoa031467","article-title":"Tanapox infection in a college student","volume":"350","author":"Dhar","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0035-9203(02)90295-6","article-title":"Tanapox: first report in a European traveller and identification by PCR","volume":"96","author":"Stich","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0055","first-page":"441","article-title":"Investigation of buffalopox outbreaks in Maharashtra State during 1992\u20131996","volume":"106","author":"Kolhapure","year":"1997","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0060","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/0008-5472.CAN-12-2448","article-title":"Phase I trial of recombinant modified vaccinia ankara encoding Epstein\u2013Barr viral tumor antigens in nasopharyngeal carcinoma patients","volume":"73","author":"Hui","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0065","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/1078-0432.CCR-12-2478","article-title":"Serum antibodies to blood group A predict survival on PROSTVAC-VF","volume":"19","author":"Campbell","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0070","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiq105","article-title":"National Institute of A Infectious Diseases HIVVTN. Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"203","author":"Goepfert","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/hv.21080","article-title":"A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication","volume":"8","author":"Verardi","year":"2012","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0080","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0090","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January\u2013October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3201\/eid1005.030967","article-title":"Smallpox vaccination and adverse cardiac events","volume":"10","author":"Upfal","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0100","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"ECP"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/aje\/kwh269","article-title":"Myopericarditis following smallpox vaccination","volume":"160","author":"Arness","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2004.05.004","article-title":"Department of Defense Smallpox Vaccination Clinical Evaluation T. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination","volume":"44","author":"Eckart","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0115","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.03481-12","article-title":"Assessment of the protective effect of imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques","volume":"87","author":"Hatch","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2005.08.008","article-title":"Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin","volume":"343","author":"Jones-Trower","year":"2005","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2014.05.018_bib0125","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1128\/JVI.00264-12","article-title":"Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation","volume":"86","author":"Guzman","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0130","first-page":"2034","article-title":"The clinical diagnosis of smallpox and smallpox-like diseases","volume":"108","author":"Hermans","year":"1964","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0923-2516(89)80131-1","article-title":"Live poxvirus-vectored vaccines in wildlife immunization programmes: the rabies paradigm","volume":"140","author":"Esposito","year":"1989","journal-title":"Res Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01309757","article-title":"Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep","volume":"133","author":"DeMartini","year":"1993","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0145","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0264-410X(97)00062-5","article-title":"Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine","volume":"15","author":"Hu","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7589\/0090-3558-27.4.681","article-title":"Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein","volume":"27","author":"Fekadu","year":"1991","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4615-1899-0_36","article-title":"Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus","volume":"380","author":"Wasmoen","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/10611860410001670062","article-title":"Raccoon poxvirus as a mucosal vaccine vector for domestic cats","volume":"11","author":"Osorio","year":"2003","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0165","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0170","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1128\/JVI.03038-12","article-title":"The orchestrated functions of innate leukocytes and T cell subsets contribute to humoral immunity, virus control, and recovery from secondary poxvirus challenge","volume":"87","author":"Tahiliani","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0175","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1128\/JVI.78.6.3133-3139.2004","article-title":"Vaccinia virus infection during murine pregnancy: a new pathogenesis model for vaccinia fetalis","volume":"78","author":"Benning","year":"2004","journal-title":"J Virol"},{"issue":"November (Pt 11)","key":"10.1016\/j.vaccine.2014.05.018_bib0180","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1099\/0022-1317-71-11-2761","article-title":"Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route","volume":"71","author":"Williamson","year":"1990","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.05.018_bib0185","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/JVI.01802-09","article-title":"The Poxvirus A35 Protein is an Immunoregulator","volume":"84","author":"Rehm","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0190","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2007.11.045","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination","volume":"26","author":"Vijaysri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0195","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.66.5.2617-2630.1992","article-title":"Molecular attenuation of vaccinia virus: mutant generation and animal characterization","volume":"66","author":"Lee","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.05.018_bib0200","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/mt.2010.14","article-title":"Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity","volume":"18","author":"Evgin","year":"2010","journal-title":"Mol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T11:57:51Z","timestamp":1597838271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14006744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":40,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14006744"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raccoonpoxvirus safety in immunocompromised and pregnant mouse models","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}